Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin to reduce discomfort after ureteral stenting in urolithiasis
IRCT2015042221886N2Phase 3Completed
- Sponsor
- Exir Pharmaceutical
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tamsulosin in ureteral stent-related symptoms (USRS) and Lithiasis, sponsored by Exir Pharmaceutical. Started May 2015; status: completed.
02
Drugs
tamsulosin
03
Conditions
ureteral stent-related symptoms (USRS)Lithiasis
Beyond the preview
Go deeper on IRCT2015042221886N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015042221886N2.